Eddie Eltoukhy

Eddie currently heads life sciences investing at Pear VC, a venture firm in Menlo Park, CA, that specializes in seed-stage investments. Before joining Pear VC, Eddie led corporate development at Senti Biosciences, a company that leverages synthetic biology for next-generation cell and gene therapies, from its seed stage until just before its public financing. Eddie drove partnering collaborations with Spark/Roche in gene therapy and BlueRock/Bayer in regenerative medicine. Previously, Eddie worked at a drug delivery company spun out of MIT as a scientist in formulation and process scale-up for two ocular clinical drug candidates that are now FDA-approved products. He holds a PhD in Biological Engineering from MIT, where he pursued research on non-viral gene therapies, as well as an MBA from Stanford University’s Graduate School of Business.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.